retatrutide dosing clinical trial retatrutide dose Reta data & — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Retatrutide dosage chart for weight

GLP-1 drugs for heart health Trulicity (dulaglutide) was approved in 2020 for individuals with type 2 diabetes, with or without a history of heart disease, to help reduce the risk of serious cardiovascular events, like heart attacks

Exenatide immediate-release (Byetta): Initiation involves a 5 mcg dose administered subcutaneously twice daily, which can be increased to 10 mcg twice daily after a month if required

doi: 10.1080/08998280.2025.2456441

This list should help you build meals that are higher in protein, easier to digest, supportive of hydration, and simple enough to keep up with even on days when eating feels like a chore

The articles obtained through the search strategy were exported, and duplicates were removed using EndNote

The gut microbiome's role in GLP-1 regulation is an active area of research, with emerging evidence suggesting that microbial diversity and specific bacterial strains may influence incretin hormone secretion, but more human studies are needed to establish clinical significance